Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC

Hongling Li1, Dezhuan Da1, Wenqiang Yu2

  • 1Department of Oncology, Gansu Provincial Hospital, The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou 730000, PR China.

Insights

MicroRNA-26A1 acts as a tumor suppressor in non-small cell lung cancer (NSCLC) by reactivating genes through enhancer regulation, offering a potential new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Non-small cell lung cancer (NSCLC) exhibits downregulation of tumor suppressor genes (TSGs), but the precise mechanisms remain unclear.
  • While DNA methylation and histone modifications are implicated, their specific roles in NSCLC TSG downregulation require further elucidation.

Purpose of the Study:

  • To investigate the mechanism of TSG downregulation in NSCLC.
  • To identify the role of microRNA-26A1 (miR-26A1) in NSCLC progression and regulation.
  • To explore enhancer-mediated gene regulation in NSCLC.

Main Methods:

  • Pyrosequencing to analyze DNA methylation in VILL promoter regions.
  • Lentiviral infection to overexpress miR-26A1 in NSCLC cell lines (A549, H1703).
  • Chromatin immunoprecipitation (ChIP) assays to assess H3K27ac enrichment at enhancer regions.

Main Results:

  • No significant difference in promoter DNA methylation of most TSGs, including VILL, was observed in NSCLC compared to adjacent tissues.
  • Overexpression of miR-26A1 reactivated VILL expression in NSCLC cells, an effect inhibited by enhancer inhibitor JQ1.
  • miR-26A1 demonstrated tumor suppressor activity by inhibiting NSCLC cell proliferation and metastasis.
  • miR-26A1 overexpression led to increased H3K27ac enrichment at enhancer regions, indicating enhancer activation.

Conclusions:

  • TSG regulation in NSCLC occurs via enhancer-mediated mechanisms, not solely promoter methylation.
  • miR-26A1 functions as a crucial tumor suppressor in NSCLC by modulating enhancers.
  • miR-26A1 represents a promising therapeutic target for NSCLC treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K